|
| |
|
| December 22, |
Release |
|
| |
December 22, |
Toray, Japan Tobacco and Torii Terminate the Joint Development of nalfurafine hydrochloride (“TRK-820”) for Pruritus Associated with Liver Disease in Japan |
| |
|
| August 27, |
" Annual Report 2011(PDF) " was updated. |
| |
|
| May 11, |
" Financial
Highlights " was updated. |
| |
|
| February 7, |
Release |
|
| |
February 7, |
Torii Pharmaceutical to Launch Hyperkalemia Improvement Agent,
KAYEXALATE® DRYSYRUP 76% |
| |
|
| January 28, |
Release |
|
| |
January 28, |
ALK and Torii enter into an exclusive license agreement for allergy immunotherapy products in Japan |
| |
|
| |
|
| |
|
| August 26, |
" Annual Report 2009(PDF) " was updated. |
| |
|
| April 30, |
" Financial
Highlights " was updated. |
| |
|
| March 23, |
Release |
|
| |
March 23, |
Launch of REMITCH® CAPSULES 2.5 μg , new oral antipruritus drug |
| |
|
| January 21, |
Release |
|
| |
January 21, |
Manufacturing and marketing approval
for REMITCH® CAPSULES 2.5 μg , oral antipruritus drug, in Japan |
| |
|
| January 13, |
Release |
|
| |
January 13, |
Torii Pharmaceutical to Solely Market Antiemetic Drugs
"Serotone® I.V. Injection 10 mg" and "Serotone® Tablets 10 mg" |
| |
|
| |
|
| |
|
| December 26, |
Release |
|
| |
December 18, |
Torii Pharmaceutical and Minophagen Pharmaceutical to Phase Out Basic Trade Agreement |
| |
|
| October 31, |
Release |
|
| |
October 31, |
Future Marketing and Distribution Organization for DOVONEX® Ointment for the Treatment of Psoriasis Vulgaris |
| |
|
| September 26, |
Release |
|
| |
September 26, |
JT and Torii Sign Licensing Agreement with Keryx for Development and Commercialization of Hyperphosphatemia Drug in Japan |
| |
|
| August 27, |
" Annual Report 2007(PDF) " was updated. |
| |
|
| July 6, |
Release |
|
| |
July 6, |
Torii Pharmaceutical to Launch Antifungal Agent for External Use, "ZEFNART SOLUTION 2%", in Japan |
| |
|
| June 29, |
Release |
|
| |
June
29, |
Torii,
Toray starts to Co-Promote Hemoperfusion absorption column "Toraymyxin"
for removing endotoxin |
| |
|
| April 27, |
" Financial
Highlights " was updated. |
| |
|
| |
|
| |
|
| November 28, |
Release |
|
| |
November 28, |
New Drug Application of Antipruritic Agent "TRK-820" for the Treatment of Severe Pruritus in Hemodialysis Patients in Japan |
| |
|
| September 4, |
Release |
|
| |
September 4, |
Toray, JT, Torii Agree to Co-Develop and Market TRK-820 Antipruritus Drug for Hepatic Disease Patients in Japan |
| |
|
| August 28, |
" Annual
Report 2006 (PDF) " was updated. |
| |
|
| August 4, |
Release |
|
| |
August 3, |
Conclusion of an Agreement over Co-promotion of Dops® for the Treatment of Orthostatic Hypotension |
| |
|
|
| April 28, |
" Financial
Highlights " was updated. |
| |
|
| |
|
| |
|
| August 24, |
" Annual Report 2005 (PDF) " was updated. |
| |
|
|
| April 27, |
" Financial
Highlights " was updated. |
| |
|
|
| April 22, |
Release |
|
| |
April 22, |
JT Group to Merge Pharmaceutical Production Facilities |
| |
|
|
| April 8, |
Release |
|
| |
April 8, |
JT and Torii Pharmaceutical to Launch New HIV Treatment Drugs in Japan |
| |
|
|
| March 17, |
Release |
|
| |
March 16, |
Toray, Japan Tobacco, Torii Pharmaceutical Agree to Co-Develop and Market New Antipruritus Drug in Hemodialysis Patients in Japan |
| |
|
|
| |
|
|
|
|
| Changes / Renewal
